Researchers have uncovered why livers damaged by alcohol often fail to recover even after a person stops drinking. The culprit? Inflammation-driven errors in RNA splicing that trap liver cells in a dysfunctional middle state — neither fully mature nor able to regenerate. The findings, published in Nature Communications, point to a potential new treatment pathway and diagnostic markers for alcohol-associated liver disease.

Scientists from the University of Illinois Urbana-Champaign, Duke University, and the Chan Zuckerberg Biohub Chicago found that in diseased livers, cells begin the regeneration process but get stuck halfway. A key protein called ESRP2 — which normally ensures RNA is spliced correctly — is suppressed by inflammatory signals triggered by alcohol metabolism. Without it, proteins critical for regeneration end up in the wrong part of the cell, rendering them functionally useless even when present in normal amounts. In lab experiments, blocking one inflammatory signal restored ESRP2 levels and normalized RNA splicing.

Key Takeaways:

• Liver cells in alcohol-associated hepatitis/cirrhosis become trapped in a "quasi-progenitor" state — unable to function or fully regenerate
• ESRP2 deficiency, driven by inflammation, causes widespread RNA mis-splicing across thousands of genes
• Blocking inflammatory receptor signaling restored normal splicing in lab cultures, suggesting a targetable pathway
• Mis-spliced RNAs may serve as future diagnostic biomarkers for alcohol-associated liver disease

Why it matters: Liver transplantation is currently the only life-saving option for end-stage alcohol-related liver disease, which causes approximately 3 million deaths annually. This research opens the door to therapies that could restart the liver's own repair system — potentially transforming outcomes for millions of patients.